Ventripoint Diagnostics Ltd
(MENAFN- Baystreet) 10:01 AM EST - Ventripoint Diagnostics Ltd: Announces that subject to approval of TSX Venture Exchange, it has increased the size and closed the second and final tranche of its previously announced non-brokered private placement of up to 4,024,250 units at a price of $0.10 per Unit. The first tranche of the Offering closed on September 8, 2026 with the issuance of 1,800,000 Units. The second and final tranche of the Offering has closed with the issuance of an additional 2,224,250 Units. The Corporation issued an aggregate of $222,425 of Units pursuant to the Offering. Ventripoint Diagnostics Ltd
shares V are trading up one cent at $0.07.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment